Tangent Medical Technologies provides intravenous catheters and associated products for the improvement of infusion therapy.
Tangent Medical Technologies, a development stage medical device company, was founded in Ann Arbor in 2009 based on technology exclusively licensed from the University of Michigan's Medical Innovation Center. The Company's mission is to improve infusion therapy for patients and healthcare workers with its proprietary, intravenous catheters and associated products. Tangent is led by an experienced, successful management team and the original inventors of the technology. The Company expects to begin generating commercial revenues from its lead product, the NovaCath⢠Closed IV Catheter System, in 2012.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 14, 2012 | Series B | $8.62M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
University of Michigan Investment in New Technologies Fund | — | Series B |